Ischemia-modified albumin and fibulin-5 as diagnostic and prognostic markers for acute cerebrovascular disease

Abstract Background Fibulin-5 and ischemia-modified albumin (IMA) levels increase in acute phase of cerebrovascular diseases, yet data regarding their levels in various stroke subtypes and correlation with severity and prognosis are still insufficient. This work aims to evaluate serum IMA and fibuli...

Full description

Bibliographic Details
Main Authors: Hosna S. Elshony, Mohammed A. Okda, Rasha A. El-Kabany
Format: Article
Language:English
Published: SpringerOpen 2021-01-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
IMA
Online Access:https://doi.org/10.1186/s41983-020-00264-2